131 related articles for article (PubMed ID: 10888110)
1. Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia.
Saitoh M; Taguchi K; Yasuda S; Kikumori M; Nishimori T; Suda M; Okamiya H; Usuda S; Miyata K
J Interferon Cytokine Res; 2000 Jun; 20(6):539-45. PubMed ID: 10888110
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
Schlerman FJ; Bree AG; Kaviani MD; Nagle SL; Donnelly LH; Mason LE; Schaub RG; Grupp SA; Goldman SJ
Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.
Akahori H; Shibuya K; Obuchi M; Nishizawa Y; Tsuji A; Kabaya K; Kusaka M; Ohashi H; Tsumura H; Kato T; Miyazaki H
Br J Haematol; 1996 Sep; 94(4):722-8. PubMed ID: 8826901
[TBL] [Abstract][Full Text] [Related]
4. The role of recombinant interleukin 11 in megakaryocytopoiesis.
Turner KJ; Neben S; Weich N; Schaub RG; Goldman SJ
Stem Cells; 1996; 14 Suppl 1():53-61. PubMed ID: 11012203
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.
Tanaka S; Tabuchi S; Watanabe K; Takigawa H; Akatsuka K; Numata H; Hokama Y; Hori T
J Neurooncol; 1992 Oct; 14(2):159-68. PubMed ID: 1331350
[TBL] [Abstract][Full Text] [Related]
6. [Application of interleukin 1 in the treatment of malignant gliomas with special reference to the experimental combination therapy with ACNU].
Tanaka S
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1157-64. PubMed ID: 2350191
[TBL] [Abstract][Full Text] [Related]
7. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.
Goldman SJ
Stem Cells; 1995 Sep; 13(5):462-71. PubMed ID: 8528095
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effect of recombinant human interleukin-11 on thrombocytopenia models induced by anti-platelet serum in guinea pigs].
Lai FY; Fang F; Sun L
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):19-20. PubMed ID: 12575223
[TBL] [Abstract][Full Text] [Related]
9. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice.
Saitoh M; Taguchi K; Momose K; Suga K; Ogawa Y; Yasuda S; Miyata K
Cytokine; 2001 Mar; 13(5):287-94. PubMed ID: 11243707
[TBL] [Abstract][Full Text] [Related]
11. Effects of rhIL-11 on normal dogs and after sublethal radiation.
Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
[TBL] [Abstract][Full Text] [Related]
12. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
Kaye JA
Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
[TBL] [Abstract][Full Text] [Related]
13. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
14. Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia.
Shiotsu Y; Yamashita K; Kanai F; Ikuina Y; Murakata C; Teramura M; Mizoguchi H; Tamaoki T; Akinaga S
Blood; 2000 Jun; 95(12):3771-80. PubMed ID: 10845909
[TBL] [Abstract][Full Text] [Related]
15. The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression.
Farese AM; MacVittie TJ; Lind LB; Smith WG; McKearn JP
Stem Cells; 1998; 16 Suppl 2():143-54. PubMed ID: 11012186
[TBL] [Abstract][Full Text] [Related]
16. Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates.
Farese AM; Smith WG; Giri JG; Siegel N; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(4):329-38. PubMed ID: 11463953
[TBL] [Abstract][Full Text] [Related]
17. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
[TBL] [Abstract][Full Text] [Related]
18. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor.
Yonemura Y; Kawakita M; Miyake H; Miyazoe T; Fujimoto K; Takatsuki K
Int J Hematol; 1997 Jun; 65(4):397-404. PubMed ID: 9195779
[TBL] [Abstract][Full Text] [Related]
20. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
